You are in:Home/Publications/IL18 GENE PROMOTER -607A/C AND -137G/C POLYMORPHISMS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Prof. Yasser Mahmoud Mohammad Ismail :: Publications:

Title:
IL18 GENE PROMOTER -607A/C AND -137G/C POLYMORPHISMS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Authors: Gehan G. El-Olemy MD, Eman R. Abdelgwad MD, Yasser M. Ismail MD and Abeer A. Aboelazm MD
Year: 2011
Keywords: Not Available
Journal: Not Available
Volume: Not Available
Issue: Not Available
Pages: Not Available
Publisher: Not Available
Local/International: Local
Paper Link: Not Available
Full paper Yasser Mahmoud Mohammad Ismail_01 Paper 2013-12-16.pdf
Supplementary materials Not Available
Abstract:

Objective: To analyze the association of IL-18 promoter gene polymorphisms (-607A/C and -137C/G) with disease susceptibility and manifestations of SLE patients. Methods: Forty seven SLE patients and 50 unrelated healthy subjects (a control group) were included. All SLE patients underwent thorough clinical examination and SLE disease activity assessment using SLEDAI. The IL-18 polymorphisms were genotyped by PCR amplification and RFLP analysis while, IL- 18 plasma levels were determined by ELISA for both patients and controls. Results: Our data indicated that the frequency of genotype -607/AC (P=0.04, OR: 2.58, 95% CI: 1.01-6.6) was significantly increased and the frequency of genotype –137/CC (P=0.049, OR: 0.27, 95% CI: 0.07-1.06) was significantly decreased in SLE patients. In addition, -607/CC genotype frequency was significantly increased in patients with serositis (X2=6.75, P=0.03) while genotype -137/GG was significantly increased in patients with arthritis/arthralgia (X2=7.06, P=0.029). Significantly elevated levels of plasma IL-18 were found in patients compared to controls (P=0.002) with significant correlation with disease activity (p <0.001). Patients with AC and CC (-607), and GG and GC (-137) genotypes have significantly higher IL-18 levels than those with AA and CC genotypes (P<0.001). Significantly higher IL-18 levels were found in control subjects with AC and CC (-607) genotypes (P=0.014). Conclusion: Our results have provided evidence that IL18 promoter gene polymorphisms at position –607 and –137 contribute to genetic background of SLE susceptibility and presentation, as well as enhanced production of IL-18 protein in SLE patients. Keywords: Gene polymorphisms , Single nucleotide polymorphisms, Interleukin 18 , SLE.

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus